| 标题 |
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hepatology International 作者:Shigeo Shimose; Issei Saeki; Takanori Ito; Yasuto Takeuchi; Joji Tani; et al 出版日期:2025-02-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)